Green light for Amber’s bone research
Done deal: Bone repair technology collaboration
The clincher: “Today’s announcement on the new scaffold technology demonstrates our track record of pushing the boundaries of science to discover real solutions. We will continue to carry out excellent research that has clear societal impact” - professor Stefano Sanvito, acting director, Amber.
HydroxyColl has been developed by the Royal College of Surgeons in Ireland (RCSI) in collaboration with Amber, a research centre for materials science based in...
Subscribe from just 1€
Choose the subscription that is right for you
For the first month
€19.99 Monthly ThereafterSubscribe today
For the first year
€199.99 annually thereafterSubscribe today
For the first 90 days
€55.00 quarterly ThereafterSubscribe today
These offers are not available for current subscribers. Offers and pricing are subject to change without notice.
Terms & Conditions Apply